Back to News
Market Impact: 0.2
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Bronstein, Gewirtz & Grossman announced that a securities class-action lawsuit has been filed against Replimune Group (NASDAQ: REPL) and certain officers. The release provides no allegations, damages, financial impact, or case timeline, but the litigation introduces a potential legal and reputational overhang for the biotech company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
REPL-0.85
More News
- Aker BP Q3 profit tops forecast on $870 million writedown reversal
- Kalshi, co-founders hit with criminal charges in US state of Utah
- Judge says Trump's bid to set aside California ballots would ‘wreak havoc’ on democracy
- Bausch Health raises 2026 outlook as third-quarter adjusted earnings surge 53%
- Utah criminally charges Kalshi with promoting illegal gambling
- FTC and 20 states sue Dollar General, saying it overcharged its poorest customers by millions
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- Automating Financial Model Updates: A Source-Controlled Workflow
- Weekly Update: Sector Analysis, Improvements on Research Data, and Performance Enhancements